1. Co-targeting p53-R249S and CDK4 synergistically suppresses survival of hepatocellular carcinoma cells. Issue 3 (3rd March 2020) Authors: Wang, Huai; Liao, Peng; Zeng, Shelya X.; Lu, Hua Journal: Cancer biology & therapy Issue: Volume 21:Issue 3(2020) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determination of maximum tolerated dose and toxicity of Inauhzin in mice. (2015) Authors: Zhang, Qi; Zeng, Shelya X.; Lu, Hua Journal: Toxicology reports Issue: Volume 2(2015) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Determination of maximum tolerated dose and toxicity of Inauhzin in mice. (2015) Authors: Zhang, Qi; Zeng, Shelya X.; Lu, Hua Journal: Toxicology reports Issue: Volume 2(2015) Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ribosomopathies: Mechanisms of Disease. Issue 7 (January 2014) Authors: Nakhoul, Hani; Ke, Jiangwei; Zhou, Xiang; Liao, Wenjuan; Zeng, Shelya X.; Lu, Hua Journal: Clinical medicine insights Issue: Issue 7(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗